No Association between Gastrointestinal Rebleeding and DOAC Therapy Resumption: A Systematic Review and Meta-Analysis.
Dániel PálinkásBrigitta TeutschEndre Botond GagyiMarie Anne EnghPatrícia KallóDániel Sándor VeresLászló Földvári-NagyNóra HosszúfalusiPéter HegyiBálint ErőssPublished in: Biomedicines (2023)
DOAC resumption after a GIB episode may not elevate the risk of rebleeding. However, the need for high-quality randomized clinical trials is crucial.